Skip to the main content.
Login Contact us

1 min read

Cloud Breast AI Solution With The Fastest Turnaround Time

Cloud Breast AI Solution With The Fastest Turnaround Time

Harnessing its expertise in Cardio AI, Neuro AI, Lung AI, and Chest | MSK AI, Arterys has become the first and only cloud-native provider of Breast AI imaging technology. Arterys’ solution dramatically reduces tomosynthesis (3D Mammography) reading times, allowing batch or live readings while the patient is still in the office for triage and supplemental screening. 

Benefits of Improving TAT

With Radiologists facing heavier workloads than ever, making the time between when an imaging exam is acquired and AI results are available to the radiologist has many impacts on workflow and productivity. 

Improving TAT:

  • Reduces image reading time and reporting
  • Improve productivity and efficiency
  • Results available faster for radiologist and patients
  • Improves throughput of imaging exams
  • Shorter appointment times 

Dramatically Reduced Turnaround Time (TAT) for 3D Tomosynthesis 

The Arterys development team, with an average of 20 years experience, has spent the past two years to effectively reduce the TAT from 45 minutes to 2 minutes for all solutions. Here’s a typical breakdown of TAT of a clinical 3D tomosynthesis analyzed with Arterys’ Breast AI.

turnaround time tomosynthesis


Learn More About Arterys' Breast AI Imaging Technology

Arterys' Breast AI provides AI solutions for breast cancer detection, breast density measurement, and personalized risk assessment that offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes.

Arterys gives radiologists and physicians:

  • Superior Accuracy

      • Improve breast cancer detection and accurately identify women at high risk of developing breast cancer in the short term

scan accuracy

  • Increased Efficiency

      • Reduce reading time by as much as 52.7% with automated detection and analysis of DTB images which assists in prioritizing caseloads and clinical decision-making
  • Optimized Workflow

      • Anytime, anywhere, access to results through a single user interface zero-footprint viewer and an internet connection - No on-premises hardware required
  • Consistent Results

    • Simplify and standardize breast density stratification and reporting with accurate and reliable results

Want to know more?

Breast AI provides cloud-native AI solutions for breast cancer detection, breast density measurement, and personalized risk assessment that offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes. Let us show you how!

Schedule a Demo

 

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software company providing AI...

Read More
Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and healthcare professionals involved in...

Read More
March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

There are a lot of radiology conferences and events in March, and you can connect with the Arterys team at a number of them! Six specific events in...

Read More
Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.